# Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells

> **NCT05535803** · PHASE2 · UNKNOWN · sponsor: **Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus** · enrollment: 20 (estimated)

## Conditions studied

- Tracheal Stenosis
- Laryngeal Stenosis

## Interventions

- **BIOLOGICAL:** Olfactory mucosa-derived mesenchymal stem cells
- **OTHER:** Patients treated according to current clinical protocols

## Key facts

- **NCT ID:** NCT05535803
- **Lead sponsor:** Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05535803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05535803, "Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05535803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*